Get started
Author

Rafael Ayerbe-Algaba

Observed names: R. Ayerbe Algaba, Rafael Ayerbe Algaba
ORCID: 0000-0002-2894-3866
Observed ORCID: 0000-0002-2894-3866
OpenAlex ID: A5022362699
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
2019 · Andrea Miró-Canturri, Rafael Ayerbe-Algaba, et al. · Frontiers in Microbiology · 212
Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria
2020 · Andrea Vila Domínguez, Rafael Ayerbe Algaba, et al. · Antibiotics · 123
PDF
Combating virulence of Gram-negative bacilli by OmpA inhibition
2017 · Xavier Vila-Farrés, Raquel Parra-Millán, et al. · Scientific Reports · 82
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
2018 · Rafael Ayerbe-Algaba, María Luisa Gil-Marqués, et al. · Frontiers in Cellular and Infection Microbiology · 75
Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB
2018 · Raquel Parra-Millán, David Guerrero-Gómez, et al. · mSphere · 59
PDF
The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli
2019 · Rafael Ayerbe-Algaba, María Luisa Gil-Marqués, et al. · International Journal of Antimicrobial Agents · 39
Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models
2016 · R. Parra Millán, M. E. Jiménez Mejías, et al. · Antimicrobial Agents and Chemotherapy · 39
PDF
Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy
2018 · Raquel Parra-Millán, Xavier Vila-Farrés, et al. · Journal of Antimicrobial Chemotherapy · 38
PDF
Repositioning rafoxanide to treat Gram-negative bacilli infections
2020 · Andrea Miró-Canturri, Rafael Ayerbe-Algaba, et al. · Journal of Antimicrobial Chemotherapy · 32
Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
2021 · Andrea Miró-Canturri, Rafael Ayerbe-Algaba, et al. · Antibiotics · 24
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections
2021 · Andrea Miró-Canturri, Andrea Vila-Domínguez, et al. · Microbiology Spectrum · 15
Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
2021 · Andrea Miró-Canturri, Rafael Ayerbe-Algaba, et al. · Pharmaceuticals · 12
AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections
2021 · Rafael Ayerbe-Algaba, Nuria Bayó, et al. · Frontiers in Microbiology · 11
Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models
2021 · Andrea Miró-Canturri, Rafael Ayerbe-Algaba, et al. · Antibiotics · 8
Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy
2022 · Raquel Parra-Millán, Manuel E. Jiménez-Mejías, et al. · Enfermedades infecciosas y microbiologia clinica (English ed ) · 5
Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy
2020 · Raquel Parra-Millán, Manuel E. Jiménez-Mejías, et al. · Enfermedades Infecciosas y Microbiología Clínica · 5
PDF
Escherichia coli causing meningitis in an adult: A case report and experimental characterization of its virulence
2018 · Rafael Ayerbe Algaba, Rocio Álvarez-Marín, et al. · Enfermedades Infecciosas y Microbiología Clínica · 5
The oxidative potential of nanomaterials: an optimized high-throughput protocol and interlaboratory comparison for the ferric reducing ability of serum (FRAS) assay
2024 · Nienke Ruijter, Matthew Boyles, et al. · Nanotoxicology · 3
Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections
2022 · Andrea Miró-Canturri, Rafael Ayerbe-Algaba, et al. · Frontiers in Microbiology · 1
Uso de fármacos, con mecanismo de acción sobre la pared bacteriana, como adyuvante al tratamiento antimicrobiano para las infecciones causadas por bacilos Gram-negativos multirresistentes
2019 · Rafael Ayerbe-Algaba · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Escherichia coli causing meningitis in an adult: A case report and experimental characterization of its virulence
2019 · Rafael Ayerbe Algaba, Rocio Álvarez-Marín, et al. · Enfermedades infecciosas y microbiologia clinica (English ed )
Synergic effect of oxyclozanide in combination with colistin against colistin-resistant and colistin-susceptible clinical strains of Klebsiella pneumoniae .
2016 · Cristina Cerrada Romero, Rafael Ayerbe-Algaba, et al. · Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria
Works count: 22
Citation count: 788
H-index: 12
I10-index: 13
Year
Topic
Type